Cancer research
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Cancer research | |
|
Articles | |
|---|---|
|
Most recent articles on Cancer research Most cited articles on Cancer research | |
|
Media | |
|
Powerpoint slides on Cancer research | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Cancer research at Clinical Trials.gov Trial results on Cancer research Clinical Trials on Cancer research at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Cancer research NICE Guidance on Cancer research
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Cancer research Discussion groups on Cancer research Patient Handouts on Cancer research Directions to Hospitals Treating Cancer research Risk calculators and risk factors for Cancer research
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Cancer research | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Cancer research is research into cancer in order to identify causes and develop strategies for prevention, diagnosis, treatments and cure.
Cancer research ranges from epidemiology, molecular bioscience (bench research) to the performance of clinical trials to evaluate and compare applications of the various cancer treatment. These applications include surgery, radiation therapy, chemotherapy and hormone therapy, and combined treatment modalities such as chemo-radiotherapy. Starting in the mid-1990s, the emphasis in clinical cancer research shifted towards therapies derived from biotechnology research, such as immunotherapy and gene therapy.
Areas of research
Cause
This type of research involves many different disciplines including genetics, diet, environmental factors (ie chemical carcinogens).
Genes involved in cancer
As the Cancer Genome Project stated in a 2004 review article, "a central aim of cancer research has been to identify the mutated genes that are causally implicated in oncogenesis (cancer genes)."[1]
Several hereditary factors can increase the chance of cancer-causing mutations, including the activation of oncogenes or the inhibition of tumor suppressor genes. The functions of various onco- and tumor suppressor genes can be disrupted at different stages of tumor progression. Mutations in such genes can be used to classify the malignancy of a tumor.
In later stages, tumors can develop a resistance to cancer treatment. The identification of oncogenes and tumor suppressor genes is important to understand tumor progression and treatment success.
Genes and protein products that have been identified by at least two independent publications as being involved in cancer are: ABI1, ABL2, ACSL6, AF1Q, AF5Q31 (also known as MCEF), AKT1, ARNT, ASPSCR1, ATF1, ATIC, BCL10, BFHD, BIRC3, BMPR1A, BTG1, CBFA2T1, CBFA2T3, CBFB, CCND1, CDC2, CDK4, CHIC2, CHN1, COPEB, COX6C, CTNNB1, CYLD, DDB2, DDIT3, DEK, EIF4A2, EPS15, ERCC2, ERCC3, ERCC5, ERG, ETV4, ETV6, EWSR1, EXT1, EXT2, FANCC, FANCG, FGFR1OP, FGFR3, FH, FIP1L1, FUS, GAS7, GATA1, GMPS, GOLGA5, GPC, GPHN, HIST1H4I, HRAS, HSPCA, IL21R, IRF4, KRAS2, LASP1, LCP1, LHFP, LMO2, LYL1, MADH4, MLF1, MLH1, MLLT3, MLLT6, MNAT1, MSF, MSH2, MSN, MUTYH, MYC, NCOA4, NF2, NPM1, NRAS, PAX8, PCBD, PDGFB, PIM1, PLK2, PNUTL1, POU2F1, PPARG, PRCC, PRKACB, PRKAR1A, PTEN, PTPN11, RABEP1, RAD51L1, RAP1GDS1, RARA, RB1, RET, RHOH, RPL22, SBDS, SDHB, SEPTIN6, SET, SH3GL1, SS18L1, SSX1, SSX2, SSX4, STAT3, TAF15, TCF12, TCL1A, TFE3, TFEB, TFG, TFPT, TFRC, TNFRSF6, TP53, TPM3, TPM4, TRIP11, VHL, WAS, WT1, ZNF198, ZNF278, ZNF384, ZNFN1A1 Based on a study by M. R Straton and co-workers " A census of human cancer genes".
Treatment
Current topics of cancer treatment research include:
- Chemotherapy
- Radiation therapy
- Boosting the immune system
- Gene Therapy[1]
- Targeted therapy
Specific treatment research topics
Dichloroacetate
In January 2007 researchers of the University of Alberta reported preliminary results of dichloroacetate (DCA) causing regression in several cancers in vitro, including lung, breast and brain tumors.[1] Since the compound DCA itself cannot be patented it could be an inexpensive alternative to other treatments, depending of course on whether the method of using DCA in the treatment of cancer is patentable. Clinical use of DCA will of course require further public/private investment for clinical trials.[1] The initial research was funded by the Canadian Institutes of Health Research.[1]
Prevention
- Vaccines (see HPV Vaccine)
- Recent research may indicate a connection between Vitamin D deficiency and cancer.[1]
Funding
Some methods, like Dichloroacetate, cannot be patented and thus would not garner the investment interest towards research from the pharmaceutical industry.[1]
Stemcell research
Clinical trials
Organizations
- American Association for Cancer Research
- Cancer Research UK
- Cancer Research (journal)
- Dana-Farber/Harvard Cancer Center
- Institute of Cancer Research
- Ludwig Institute for Cancer Research
- [United Devices Cancer Research Project
- NCI-designated Cancer Center
- Memorial Sloan-Kettering Cancer Center
- E-Foundation for Cancer Research
- Friends of Cancer Research
- Walker Cancer Research Institute
See also
References
External links
- Cancer Genome Anatomy Project @ The NIH
- CBC Digital Archives – Cancer Research: The Canadian Quest for a Cure
- The Integrative Cancer Biology Program @ National Cancer Institute
- Dana-Farber/Harvard Cancer Center
- Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era? PDF of a scientific paper by researchers from the University of Toronto, Canada
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
